Salim Ismail, Founding Executive Director, Singularity University, gives you the top 5 medical breakthroughs by 2020 that will revolutionize medicine in the healthcare sector. Read more about Salim…
Jack Andraka, recipient of the 2012 Gordon E. Moore Award, explains the process of developing a cheap, fast, and 100% accurate diagnostic test for pancreatic cancer. Drawing from…
NEW YORK (Reuters Health) – A small study indicates that most patients with cutaneous B-cell lymphoma who respond well to rituximab relapse after about two years. On the…
NEW YORK (Reuters Health) – Contrary to a historically pessimistic outlook, high-risk prostate cancer can be controlled with moderate high-dose radiation treatment and prolonged androgen-deprivation therapy (ADT). That…
By Will Boggs, MD NEW YORK (Reuters Health) – Carboplatin plus pemetrexed improves survival over pemetrexed alone in ambulatory patients with advanced non-small-cell lung cancer (NSCLC), randomized trial…
NEW YORK (Reuters Health) – An updated meta-analysis supports the strategy of giving intravesical chemotherapy (IVC) immediately after bladder tumor resection to reduce the risk of recurrence. “However,…
NEW YORK (Reuters Health) – The cumulative incidence of osteonecrosis of the jaw was about 2% over 6 years among women with early breast cancer who received intensive…
NEW YORK (Reuters Health) – Morbidity associated with inguinal lymphadenectomy in patients with penile carcinoma has declined, and is “reasonable” considering the potential benefit, a Brazilian team reports.…
By David Douglas NEW YORK (Reuters Health) – Dual HER2 blockade didn’t increase heart problems in a meta-analysis of data from patients with HER2-positive breast cancer. “The combination…
NEW YORK (Reuters Health) – For patients with head and neck or esophageal cancer undergoing chemoradiotherapy, enteral nutrition enriched with n-3 fatty acids helps preserve body mass. The…